California Public Employees Retirement System Immunovant, Inc. Transaction History

California Public Employees Retirement System

  • $141 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$9.4 - $16.85 $648,007 - $1.16 Million
-68,937 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$13.08 - $49.6 $106,170 - $402,603
-8,117 Reduced 10.53%
68,937 $1.11 Million
Q4 2020

Feb 02, 2021
SELL
$36.36 - $52.71 $113,588 - $164,666
-3,124 Reduced 3.9%
77,054 $3.56 Million
Q3 2020

Nov 05, 2020
BUY
$22.61 - $38.9 $855,946 - $1.47 Million
37,857 Added 89.45%
80,178 $2.82 Million
Q2 2020

Aug 12, 2020
BUY
$13.87 - $28.44 $586,992 - $1.2 Million
42,321 New
42,321 $1.03 Million

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email